Noriko Suzuki Selected Research

N- (7- (1- hydroxyethyl)- 3- (4- isopropylphenyl)- 4,6- dimethyl- 2,3- dihydro- 1- benzofuran- 5- yl)- 3,3- dimethylbutanamide

8/2013	Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
1/2012	Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
1/2012	Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriko Suzuki Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 06/2005
6	Inflammation (Inflammations) 04/2017 - 10/2005
5	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 01/2015
5	Schizophrenia (Dementia Praecox) 01/2019 - 03/2016
4	Cognitive Dysfunction 12/2019 - 02/2003
4	Polyps 01/2018 - 03/2002
4	Fibrosis (Cirrhosis) 02/2009 - 10/2005
3	Hemorrhage 01/2021 - 09/2006
3	Atherosclerosis 01/2017 - 03/2010
3	Pain (Aches) 12/2015 - 06/2002
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2013 - 01/2012
3	Infarction (Infarctions) 08/2013 - 01/2012
3	Vascular System Injuries 07/2011 - 02/2003
3	Hypertension (High Blood Pressure) 02/2008 - 02/2003
2	Adenoma (Adenomas) 01/2021 - 02/2007
2	Neurobehavioral Manifestations 01/2019 - 11/2017
2	Infections 01/2019 - 01/2013
2	Ischemic Stroke 08/2013 - 01/2012
2	Gastroenteritis 05/2013 - 06/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2010 - 10/2005
2	Ischemia 09/2010 - 05/2002
2	Pelvic Pain 09/2010 - 04/2010
2	Infertility (Sterility) 09/2010 - 04/2010
2	Heart Failure 02/2009 - 05/2002
2	Taste Disorders (Taste Disorder) 08/2008 - 04/2005
2	Reperfusion Injury 06/2008 - 05/2002
2	Hyperplasia 05/2008 - 09/2002
2	Obesity 10/2007 - 04/2002
1	Anemia 12/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2023
1	Carcinoma (Carcinomatosis) 07/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Influenza in Birds (Avian Flu) 01/2022
1	Autistic Disorder (Autism) 01/2021
1	Neurodevelopmental Disorders 01/2021
1	Memory Disorders (Memory Loss) 12/2019
1	Dementia (Dementias) 12/2019
1	Pathologic Processes 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Vomiting 01/2018
1	Low Cardiac Output 01/2018
1	Hypotension (Low Blood Pressure) 01/2018
1	Nausea 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

5	Polysaccharides (Glycans)IBA 01/2022 - 01/2013
4	AldosteroneIBA 07/2011 - 10/2005
3	Type 2 Cyclic Nucleotide PhosphodiesterasesIBA 12/2019 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2008
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017 - 03/2010
3	N- (7- (1- hydroxyethyl)- 3- (4- isopropylphenyl)- 4,6- dimethyl- 2,3- dihydro- 1- benzofuran- 5- yl)- 3,3- dimethylbutanamideIBA 08/2013 - 01/2012
3	Phospholipases (Phospholipase)IBA 04/2011 - 06/2008
3	Group X Phospholipases A2IBA 04/2011 - 06/2008
2	IronIBA 12/2023 - 10/2017
2	SteroidsIBA 12/2023 - 12/2015
2	Sialic AcidsIBA 01/2022 - 01/2019
2	EnzymesIBA 01/2021 - 04/2011
2	TAK-915IBA 12/2019 - 01/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2019 - 01/2012
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 03/2016
2	PyrazinesIBA 01/2018 - 01/2017
2	Antipsychotic Agents (Antipsychotics)IBA 11/2017 - 03/2016
2	Cannabinoid Receptor AgonistsIBA 08/2013 - 01/2012
2	Insulin (Novolin)FDA Link 04/2011 - 10/2007
2	Secretory Phospholipases A2IBA 04/2011 - 06/2008
2	Eplerenone (Inspra)FDA LinkGeneric 09/2010 - 04/2007
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 09/2010 - 04/2007
2	SaltsIBA 02/2009 - 02/2003
2	ZincIBA 08/2008 - 04/2005
2	Phenobarbital (Luminal)FDA Link 02/2007 - 07/2004
1	GlucocorticoidsIBA 12/2023
1	Small Interfering RNA (siRNA)IBA 07/2022
1	ApoferritinsIBA 07/2022
1	ArtesunateIBA 07/2022
1	Sialyl Lewis X AntigenIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2021
1	TAK-418IBA 01/2021
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 12/2019
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 12/2019
1	Muscarinic AntagonistsIBA 12/2019
1	Scopolamine (Hyoscine)FDA Link 12/2019
1	AcidsIBA 01/2019
1	TAK-137IBA 01/2019
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2019
1	Ionotropic Glutamate ReceptorsIBA 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 01/2019
1	SodiumIBA 01/2018
1	Neuraminidase (Sialidase)IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	Hemagglutinins (Hemagglutinin)IBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018

Therapy/Procedure

11	Therapeutics 12/2023 - 07/2004
3	Argon Plasma Coagulation 01/2018 - 03/2002
3	Colonoscopes 01/2018 - 06/2002
2	Colectomy 01/2020 - 07/2014
2	Sutures (Suture) 01/2012 - 05/2002
2	Operative Surgical Procedures 09/2010 - 04/2010
1	Patient Readmission 01/2021